Background
Patients requiring coronary intervention after acute myocardial infarction, with decompensated heart failure and multiple comorbidities, present a challenging clinical scenario. Addressing such high-risk cases has been a marked increase in the simultaneous support using microaxial flow pump devices, providing a crucial hemodynamic support during procedures.
Case summary
We report the case of a 58-year-old man, with a non-ST-segment elevation myocardial infarction in the context of a peripheral vascular surgery. Echocardiography revealed severely reduced left ventricular function and cardiac-MRI demonstrated transmural scars in all but left anterior descending artery area. Patient was of extreme high surgical risk due to the multiple comorbidities, acute decompensation heart failure and peripheral artery disease and, therefore, the heart team preferred protected percutaneous coronary intervention (PCI) over coronary artery bypass graft for revascularization. The peripheral artery disease included severely calcified ascending aorta, occlusions of both femoral arteries, the left subclavian artery, and right radial artery. Taken together, the heart team agreed on a hybrid approach with surgical implantation of Impella 5.0 via the left subclavian artery, by a single access technique. Following the intervention procedure, hemostasis of the vascular prosthesis was achieved by an Angio-Seal technique without complications. The patient recovered satisfactorily, with improved left ventricular function and discharged ten days post-procedure.
Discussion
The Single-access for high-risk PCI technique offers a standardized approach for microaxial flow pump devices such as Impella 5.0 and PCI. The subclavian artery as a single-access route for high-risk PCI, has demonstrated safety and efficacy.